(908) 425-4878


Hemophilia A Clinical Trial Starts: First Recombinant Factor VIII Derived from a Human Cell-Line

Published: Nov 1, 2010 | Last modified: Nov 1, 2010
HOBOKEN, N.J. (November 1, 2010) - Octapharma AG, one of the largest human protein products manufacturers in the world, and Octapharma USA today announced that patients diagnosed with severe hemophilia A have started treatment in a multi-center study...

Octapharma USA Accepting Applications for Research Grants Focused on Human Protein Therapies

Published: Oct 27, 2010 | Last modified: Oct 27, 2010
HOBOKEN, NJ (October 27, 2010) - Octapharma USA is accepting applications for the Octapharma 25th Anniversary Grants Program, which supports clinical or pre-clinical research focused on human protein therapies in coagulation disorders, immune therapy...

Cortes & Hay Attorney Assist Program Streamlines Real Estate Transactions for Home Buyers & Sellers

Published: Oct 25, 2010 | Last modified: Oct 25, 2010
FLEMINGTON, N.J. (October 25, 2010) - The Department of Housing and Urban Development (HUD) has significantly changed its requirements for real estate closings, adding to the complexity of property transactions and prompting Cortes & Hay, Inc. of Fle...
© Yankee Public Relations 2018 - powered by EggZack